Pharma Journalist -

Semnur Pharmaceuticals announced the commencement of phase 3 clinical trials in the U.S to evaluate its product SP-102 in patients suffering from lumbar radicular pain/sciatica. It is…
Read More...

Biopharmaceutical company Kala pharmaceuticals into development and commercialization of product candidates incorporating the usage of MPP technology declared that the New drug…
Read More...

A Shanghai-based integrated biopharmaceutical company, Jiangsu Hengrui Medicine and Arcutis, a Menlo Park, CA-based Biotechnology Company declared licensing agreement to commercialize…
Read More...

Harbour BioMed declared that it ventures into licensing agreement with BeiGene for producing human therapeutic monoclonal antibodies to a commercial-stage biopharmaceutical company that…
Read More...

SMi Group reports: If you are involved in paediatric clinical trials then SMi Groups Paediatric Clinical Trials conference, is a must attend event…and here is why… If you are looking…
Read More...

Biotechnology company heralding a new class of therapeutics based on its bicyclic peptide product platform has been provided grant from Innovate UK to develop next generation of novel…
Read More...

Xcell Biosciences initiates to accelerate its goal by considering new market opportunities in immunotherapy drug research and development. It has exhibited excellence in new…
Read More...

Clinical stage biopharmaceutical company into discovering and developing Pentarins which is a new class of potent and selective cancer medicines announced the appointment of Brian…
Read More...

AvantGen collaborates with Tanabe Research Laboratories for successful completion of first cancer therapeutic antibody discovery program. AvantGen is accountable for producing novel…
Read More...

U.S.-based multi platform gene therapy company pronounces completion of merger with Inotek pharmaceuticals that looks to combat rare diseases. The inclusive company to emphasize on…
Read More...